Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?
How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?
How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?
Submitted by
admin
on October 1, 2021 - 10:46am
Source:
Motley Fool
News Tags:
Pfizer
BioNTech
vaccines
COVID-19
pediatric
Headline:
How Big of an Opportunity Do Pfizer and BioNTech Have in Vaccinating Younger Kids?
snippet:
Pfizer and BioNTech recently announced positive data from a late-stage study in younger kids.
The companies plan to soon file for FDA authorization in this younger age group.
The market opportunity could be around $1 billion but depends heavily on vaccination rates.
Do Not Allow Advertisers to Use My Personal information